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Citizen advisory groups for the creation
and improvement of decision aids:
experience from two Swiss centers for
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Abstract
Background: Guidelines for patient decision aids (DA) recommend target population involvement throughout the
development process, but developers may struggle because of limited resources. We sought to develop a feasible
means of getting repeated feedback from users.
Methods: Between 2017 and 2020, two Swiss centers for primary care (Lausanne and Bern) created citizen advisory
groups to contribute to multiple improvement cycles for colorectal, prostate and lung cancer screening DAs.
Following Community Based Participatory Research principles, we collaborated with local organizations to recruit
citizens aged 50 to 75 without previous cancer diagnoses. We remunerated incidental costs and participant time.
One center supplemented in-person meetings by mailed paper questionnaires, while the other supplemented
meetings using small-group workshops and analyses of meeting transcripts.
Results: In Lausanne, we received input from 49 participants for three DAs between 2017 and 2020. For each topic,
participants gave feedback on the initial draft and 2 subsequent versions during in-person meetings with ~ 8
participants and one round of mailed questionnaires. In Bern, 10 participants were recruited among standardized
patients from the university, all of whom attended in-person meetings every three months between 2017 and
2020. At both sites, numerous changes were made to the content, appearance, language, and tone of DAs and
outreach materials. Participants reported high levels of satisfaction with the participative process.
Conclusions: Citizen advisory groups are a feasible means of repeatedly incorporating end-user feedback during
the creation of multiple DAs. Methodological differences between the two centers underline the need for a flexible
model adapted to local needs.
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Plain English summary
Decision aids are paper or electronic tools that help people make medical decisions. They have been shown to
help with shared decision making between patients, their loved ones, and a health professional. When we create
decision aids, we try to involve patients at each step, traditionally using focus groups. However, new approaches
are needed because focus groups take a lot of time and money.
We developed a new method of involving people eligible for cancer screening and used this method during the
development of four decision aids at two centers for research in primary care. Two of the decision aids were for
colorectal cancer screening (one in French, one in German), and one each for prostate and lung cancer screening.
We recruited people aged 50 to 75 interested in improving health information materials from community
organizations and among standardized patients from local medical schools to form citizen advisory groups.
Standardized patients act as patients during teaching sessions and exams. Some people took part in face-to-face
meetings to give us feedback on the materials, while others responded to questionnaires and gave feedback by
mail. The same participants gave feedback multiple times as we made improvements to the decision aids.
The citizen advisory groups provided us with repeated, meaningful input during the development of decision aids.
We think they allowed us to create better, more patient-centered decision aids, while using fewer resources than
traditional focus groups. Other researchers who develop decision aids may want to use a similar approach.
Keywords: Decision aids, Participatory research, Citizen involvement
Introduction
Large practice variations between physicians suggest
that their preferences often dominate those of pa-
tients when making preference-sensitive decisions [1].
Shared decision making (SDM) can help clinicians
better incorporate patient preferences [2, 3], a core
component of patient-centered care [4]. Decision aids
(DAs) support SDM by making decisions explicit,
providing reliable information about the benefits and
harms of available options, and clarifying which
choices fit with individual preferences [5]. Over 100
randomized trials have shown that DAs increase
knowledge, decrease anxiety related to choices, and
improve decision making [5].
International guidelines for the creation of DAs specify
that their development process should include a needs
assessment, review, and testing by clients or patients tar-
geted by the materials [6, 7]. Several established DA de-
velopers do extensive user-testing to ensure their DAs fit
into routine patient and provider interactions [8]. How-
ever, these approaches are very resource intensive for
smaller developers, especially if new users need to be re-
cruited to test each iteration of a DA or DAs addressing
multiple health issues in a short period of time. In our
experience, most DA developers primarily involve end
users in focus groups either for an initial needs assess-
ment or at the end of development for validation of con-
tent and messages. While focus groups are a cost-
effective means of collecting qualitative data, small re-
search groups do not have sufficient resources to allow
for testing of alternate versions of the DA or smaller
changes. New models are needed if we want to have
DAs be widely available for a large number of treatment
decisions [9].
An alternative to focus groups would be to recruit a
pool of people from the target population who can be
solicited on multiple occasions, borrowing from the
principles of Community-Based Participatory Research
[10]. The same members could meet regularly, similar to
a Community Advisory Board, though their role would
be to provide regular feedback on materials rather than
serve a leadership role in the research project. Repeated
meetings could allow iterative feedback, similar to plan-
do-study-act cycles used in quality improvement [11].
This approach would save time spent on recruitment
and allow for shorter meetings as citizens acquire ex-
pertise over time.
This paper describes the experience of two Swiss aca-
demic primary care centers who formed and maintained
citizen advisory groups. Our goal was to get repeated
feedback during the creation and improvement of mate-
rials for cancer screening. We hypothesized that such
groups could provide relevant, ongoing feedback in the
development of patient materials.
Methods
Setting
This study took place in two Swiss university centers for
primary care that develop materials for SDM. The Cen-
ter for Primary Care and Public Health (Unisanté) in
Lausanne works with local partners to provide DAs
about cancer screening. The Bern citizen advisory group
was formed in the context of a cluster randomized trial
funded by the Swiss National Science Foundation about
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patient choice in CRC screening. The trial promoted
shared decision making between general practitioners
and patients for invasive and non-invasive options for
CRC screening [12]. Principal differences in the methods
used by each center are summarized in Table 1.
Recruitment
In 2015, the Lausanne group conducted a one-year pilot
with a small citizen advisory group recruited among
standardized patients from the Lausanne medical school.
Standardized patients are trained and paid by medical
schools to act as patients during medical student exami-
nations. They represent a diverse pool of people trained
in multiple patient roles, providing feedback on medical
communication, and empathizing with problems citizens
encounter when making medical decisions [13]. In 2016
we partnered with a local organization for senior citizens
and a consumer organization to recruit additional mem-
bers to our group. Given our focus on cancer screening,
eligibility criteria were age 50 to 75 years, no previous
cancer diagnosis from the cancers being discussed, and
the ability to have spoken communication in French.
We did not have a specific information session, but the
goals of the project were explained at the first feedback
meeting. We did not get IRB approval or obtain written
consent because our project was considered quality
improvement.
The Bern group was started in late 2017, when an
email was sent to all standardized patients at the Univer-
sity of Bern inviting those aged 50 to 75 with no previ-
ous diagnosis of CRC to participate in a research group.
After an evening information session, 10 volunteered
(seven women, three men). All participants signed con-
tracts, after which we paid them 30 CHF (Swiss Francs)
per hour of work. The salary was paid once per year
directly by the Swiss National Science Foundation. This
method was approved by the local institutional review
board. Participants also signed an informed consent.
Procedure
A common element was that both Lausanne and Bern
used iterative improvement cycles and in-person meet-
ings to discuss content (Fig. 1). In Lausanne, we had six
in-person meetings over 2 years to assist in the develop-
ment of three decisions aids: three meetings to discuss
materials for colorectal cancer screening, two meetings
for prostate cancer, and one for lung cancer screening
(cut short by COVID-19 pandemic). Materials for review
were sent to participants by post at least ten days prior.
Sessions were held in the evenings with a light meal
served. We reimbursed costs of public transport or park-
ing and provided 50 CHF gift certificates after each ses-
sion. Gift certificates were used to avoid administrative
hurdles of having participants be employees. Two re-
searchers attended each meeting with one acting as
moderator and the other as note-taker, based on a semi-
structured interview guide. Participants provided overall
views on DAs, followed by a page by page review of
principal messages and wording.
In addition the Lausanne group did three rounds of
postal data collection using questionnaires (Fig. 1). Each
French-language questionnaire had three or four sec-
tions (supplementary materials): knowledge after reading
the questionnaire, screening preferences and intentions,
impressions of the materials, and feedback on the par-
ticipative process and means of disseminating the mate-
rials. Most answers were multiple choice. Our original
goal with the written questionnaires was to measure in-
formed decision making after reading the brochures
using criteria developed for a large randomized trial
Table 1 Differences in approach between Bern and Lausanne
Element Lausanne Model Bern Model
Initial inclusion in the group Individual recruitment via community partners. No contract
or informed consent
Initial information session, followed by contract
and informed consent
Group composition 59% female, mean age 62 years. Patients from our local
academic practice (30%), local consumer organization (18%),
an association for the elderly (10%), standardized patients
(10%), and personal contacts of other participants or the
researchers (32%)
70% female, mean age 65 years. Standardized
patients (100%).
Topics discussed Decision aids for colorectal, prostate and lung cancer screening Multiple documents and components of
colorectal cancer screening
Meeting frequency Average three in-person meetings and two mailings per year,
scheduled when materials became available
Two-hour, in-person meeting every quarter
Reimbursement Cost of parking and public transport; 50 CHF gift certificates
distributed to in-person and mail participants
30 CHF/hour salary, paid by the Swiss National
Science Foundation as a one-time annual bank
transfer
Information sources In-person meetings with 6 to 10 people supplemented by
mailings to an additional 30 to 40 people
In-person meetings with 7 to 10 people
employing both round-table discussions and
small-group workshops
CHF Swiss Francs
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[14]. We found that our small sample size and lack of
comparator group made it difficult to use these data.
When discussing prostate cancer screening, the in-
person meeting was limited to only men to increase
comfort discussing intimate topics, but both men and
women were submitted mailed questionnaires. Women
were asked to imagine they needed to counsel a loved
one when reviewing documents. A similar approach was
used for never-smokers and lung cancer.
In Bern meetings were held quarterly, with the group
working mainly during meetings. There was also pre-
paratory work between meetings that the individual did
at home that was also paid at 30 CHF per hour. As a
comparison, standardized patients receive 30 CHF/hour
during training and preparatory work and 50 CHF/hour
during student exams. We obtained feedback on CRC
brochures, optimal means of administering CRC screen-
ing general practice, as well as information letters.
In Bern, both discussion groups and work in small
groups (3–4 people) were used to promote the inter-
action between the group members and to generate as
diverse an input as possible in the groups (Fig. 1). The
group meetings in Bern were integrated into a random-
ized trial, and enabled the research group to present not
just information materials, but also central aspects of
their research activities. The researchers got direct feed-
back and insights from a group of persons representing
the perspective of persons invited to CRC screening.
The participants received materials to read and edit be-
fore the meetings, so that they could arrive prepared.
Two researchers were at each meeting with one serving
as moderator. All discussions were audio recorded, tran-
scribed and reviewed to ensure the accuracy of conclu-
sions. The transcripts were subjected to a basic thematic
analysis. In group work in particular, aspects emerged
that were not discussed in the plenum and were never-
theless considered important.
Patient involvement in manuscript preparation
Two members of each group were asked to participate
in the preparation of the manuscript. Given language
barriers (Lausanne is primarily French and Bern Swiss
German speaking), the abstract and portions of the main
text were translated into French and German at various
stages of preparation. They were also presented the Ta-
bles and Figures. The group members then gave verbal
feedback that was integrated by the other authors. All
authors approved the final English manuscript.
Results
Participants
Patient characteristics are provided in Table 1. Bern only
included standardized patients from the University of
Bern, as opposed to 10% of participants in Lausanne.
Ten people were at the evening information in 2018
February, and after the first meeting one person declined
further participation., as opposed to 10% of members in
Lausanne. When Lausanne participants were asked their
preferred means evaluating materials, 57% preferred
questionnaires at home, 17% preferred in-person meet-
ings, 3 9% were willing to do either, and 6% had no
preference.
Lausanne data collection and improvements to DAs
Numerous changes were made to the content, appear-
ance, language, and tone of three DAs based on the
feedback of participants (Fig. 2). Regarding participant
satisfaction, 26% of Lausanne participants said they had
Fig. 1 Model describing methodology used for improvement cycles in Lausanne and Bern. Squares in Blue show work by the research group
outside of data collection, in yellow show elements used by both centers, while green squares show elements used in just Lausanne or just Bern
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an excellent impression of their role in the group and
74% a very good impression; none responded Bad or
Very Bad. Overall retention was good in Lausanne;
participation remained stable over time and only 2
participants over 2 years asked that they no longer be
solicited.
Colorectal cancer (CRC) screening DA
The group first provided feedback on an existing
CRC screening DA and mailed letters used by several
Cantonal CRC screening programs [15]. These pro-
grams mail materials to all citizens aged 50 to 69 to
invite them to complete a fecal occult blood test or
colonoscopy. We collected information during two in-
person meetings and with a mailed questionnaire.
Ten of 12 people invited attended each meeting and
26 of 38 participants (68%) replied by mail. Because
multiple screening programs used the DA, there were
often constraints to the changes we could make,
which sometimes frustrated participants. Citizens
helped clarify messages about adenomas and the
meaning of high-risk criteria that can make people in-
eligible for the screening program. The mailed ques-
tionnaires generally showed high levels of knowledge
and preparedness for making a decision about screen-
ing, but 62% of participants thought screening was
only in case of symptoms of CRC. We therefore
added emphasis to screening definitions.
Prostate cancer screening DA
The group then provided feedback on a prostate cancer
screening DA [16], with 4 of 10 and 8 of 9 men attend-
ing two meetings and 22 of 38 people responding to a
mailed questionnaire (58%). Main messages of the bro-
chure were clarified, explaining that prostate cancer is
controversial and not supported by all professional orga-
nizations [16].
Lung cancer screening DA
Finally, the group provided feedback on a new lung can-
cer screening DA, with 9 of 12 people attending a meet-
ing and 24 of 38 people responding to a mailed
questionnaire (63%). The structure of the brochure was
adapted to emphasize smoking cessation and a section
explaining additional tests after a positive scan, such as
bronchoscopy, was shortened substantially.
Bern data collection and improvements to materials
Feedback on information materials
In the citizen group, work was carried out both in the
large group, in smaller groups and individually on spe-
cific topics for the early detection of colon cancer (Fig.
3). The group was able to provide feedback twice on the
brochure on colorectal cancer screening. In the first bro-
chure and in the current brochure on colorectal cancer
screening of the Swiss Cancer Screening, important find-
ings and details from the Bernese support group were
Fig. 2 Changes made to Lausanne decision aids based on feedback from citizen group
Selby et al. Research Involvement and Engagement            (2021) 7:37 Page 5 of 8
incorporated. Furthermore, the group developed two in-
formation letters in several sessions, one suitable for be-
ing sent out of a family doctor’s office and the other
with the sender of a screening program, the latter was
provided the screening programs. When developing
these documents, particular emphasis was placed on
simple, easy-to-understand language and clear illustra-
tions. In addition, the participants dealt with the optimal
time for the preventive consultation in a general practi-
tioner consultation as well as other possible contacts re-
garding the early detection of colorectal cancer. Another
finding out of the work with the group was the effect of
words. The choice of words can have an unsettling or
halting effect, which is particularly important in invita-
tion letter from organized screening programs, in bro-
chures and in discussions between doctors and patients.
Between seven and ten participants were present at all
meetings, with no drop-outs from the study.
Feedback on overall approach to CRC screening
One key insight from the Bern group was that the citi-
zens felt they were able to decide whether to be screened
for CRC screening and with which method on their
own, based on decision aids and information documents
received at home. This feedback was key to researchers
who had set up their research project on targeting CRC
screening decisions occurring in primary health care.
This perspective taught the researchers humility and a
wider perspective from persons invited to CRC screen-
ing. As researchers we knew general tendencies from the
scientific literature, but were reminded that individual
end-users know best what information they need and in
what format to make a satisfactory decision about
screening. Group members also mentioned they wanted
better coordination between initiatives on the state-level,
among health professionals such as pharmacists, gastro-
enterologists and primary care physicians on information
documents and messages with regards to CRC screening.
The research group, composed of primary care physi-
cians, were reminded of the need to consider the wider
healthcare system perspective for CRC screening deci-
sions in the general population. Based on this insight, re-
searchers more actively sought contact to network with
further stakeholders to disseminate their findings and in-
sights and focus on interprofessional collaboration. The
group meetings enabled researchers to learn what mat-
ters to persons invited for CRC screening. They also ex-
perienced the wide range of opinions and perspectives
from group members and that there is no solution work-
ing for all.
Discussion
This article describes the experience of two Swiss cen-
ters for primary care forming a pool of end-users to pro-
vide repeated feedback on patient DAs. During iterative
improvement cycles, the citizen-advisors provided valu-
able criticism that made materials and research projects
evolve. Participants at in-person meetings became famil-
iar with the concepts of SDM and provided higher-level
observations over time. Due to local circumstances,
there were important differences in the methodology
used in Lausanne and Bern; these contrasting experi-
ences can provide helpful insights for other DA
developers.
Our citizen-advisors commented on multiple versions
of our DAs, allowing both study groups to fulfill require-
ments in international DA guidelines for end-user feed-
back [6] without multiple cycles of recruitment to focus
groups. Going forward, the Lausanne group also intends
to pay citizen-advisors and use formal contracts, as was
done in Bern, to ensure fair compensation. Repeated
meetings with the same participants were helpful for
both groups, though differences in methodology allowed
us to attain different goals. In Lausanne, citizen-advisors
were able to provide feedback more efficiently on subse-
quent DAs, such that fewer in-person meetings were
Fig. 3 Subjects discussed at meetings in Bern
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required. However, our methodology did not allow us
to measure informed choice among participants, as
originally intended. In Bern, accumulated knowledge
about the trial within which the group was nested
[12] allowed citizen-advisors to provide critical feed-
back on our overall approach to CRC screening.
Other DA developers should value experience gained
by participants, which in our opinion outweighs the
value of participants seeing a DA for the first time.
In future studies we hope to combine feedback from
citizen-advisors with one-to-one, ‘think-aloud’ inter-
views with persons from low-literacy groups. This ap-
proach will test comprehension of DAs developed
with our current approach.
Two innovative points in our methodology should be
highlighted. First, both study sites combined elements of
community-based participatory research (CBPR) and
quality improvement to develop a pragmatic means of
involving end users in the creation of DAs. Projects
using CBPR often employ community advisory boards
(CABs) as a means of integrating stakeholders in key de-
cisions and knowing local, context-specific knowledge
[17]. We did not involve participants in strategic proto-
col decisions (aside from our dissemination plan), in the
selection of topics to discuss, or explicitly in co-design
[18]. Similar to CABs, we recruited from the population
concerned by cancer screening, asked participants to
serve as ‘representatives’ of all end-users, and maintained
the same group of participants for in-person meetings to
allow them to gain confidence and develop expertise.
We also used elements of plan-do-study-act (PDSA) cy-
cles, a methodology from quality improvement used to
provide a structure for iterative testing of changes [11].
PDSA cycles aim to adapt complex interventions for
local implementation. Though we based our initial DAs
on examples in the international literature, we needed
PDSA cycles to make the adaptations needed for suc-
cessful dissemination in Switzerland.
Second, in both the Lausanne pilot phase and the Bern
study phase, we recruited among standardized patients
from our medical schools. In our experience, they have a
heightened interest in potential improvements to the
local medical system. Standardized patients can provide
an easily-identifiable pool of participants, especially for
topics like cancer screening without identifiable patient
organizations. Standardized patients have been used pre-
viously in research projects as unannounced patients to
measure care quality [19], but not to our knowledge for
CBPR. In Lausanne, we also recruited from community
organizations, which also identified people who can
readily identify and discuss improvements to communi-
cation materials. Broadening to other sources of partici-
pants did seem to diversity the group, in having more
members working full time in more professions. One
limitation of all of our recruitment sources is that des-
pite varied levels of education attainment, nearly all of
our members seemed to have high levels of health liter-
acy, though their health literacy was not formally mea-
sured using a validated scale.
Our two study sites allocated resources differently: in
Lausanne we developed questionnaires that were mailed
to citizens not participating in in-person meetings, while
in Bern all meetings were audio-recorded, transcribed
and analyzed by one of the study authors (BM). Patterns
in responses to knowledge questions in the mailed ques-
tionnaires and written feedback provided valuable infor-
mation beyond what was collected during in-person
meetings. Questionnaires also provided individual-level
information not always captured in group discussions.
The systemic analysis of meeting transcripts by the Bern
group allowed them to avoid a possible perception bias
by the researchers, which significantly supported the
quality of the data.
Strengths of this study include its parallel imple-
mentation at two study sites, the accumulation of
3 years experiences, and patient involvement in the
preparation of the manuscript. Weaknesses include
our small sample sizes and lack of comparator group,
limiting the precision of our quantitative results and
our ability to conclusively demonstrate that we
reached our objective to develop a more efficient
method of developing DAs. Meetings in Lausanne
were not audio recorded, potentially introducing bias
in our interpretation of meeting information. Our
citizen partners participated fully in DA development
and the reporting of results, but not in the choice of
topics or the initial study protocol. As we gain confi-
dence and experience in this area, and have existing
contacts with citizen partners, we hope to involve
them as partners earlier and earlier in the research
process. Repeated meetings with the same participants
might bias their responses and make our DAs less
understandable for wider audiences. Also, we were
able to develop multiple DAs with the same members
because cancer screening is widely applicable to the
general population aged 50 to 75; DAs addressing
specific diseases will need to recruit patients with
specific experience. The participants in Bern consisted
exclusively of standardized patients, who brought with
them an affinity for medical issues. With this prior
medical knowledge, the support group likely differ
from the average end-users from the population. We
have not yet performed validation studies for our
DAs and communication materials to assess their im-
pact on routine care. Finally, because both groups
were formed to discuss cancer screening in two aca-
demic centers for primary care, it is difficult to know
the generalizability of our results.
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Conclusions
Smaller research groups like ours often struggle to in-
volve end-users during the development of DAs. We de-
scribe our experience creating and maintaining citizen
advisory groups to give repeated feedback on DAs using
principles of CBPR and PDSA cycles. We think this
pragmatic approach led to dramatic improvements in
our DAs at lower cost than other methods. Future re-
search should study the use of citizen advisory groups in
other settings, methods for maintaining our group over
time despite gaps in project-based research funding, and
the expansion of our membership to include citizens
with low health literacy.
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